HopeStage
Back to all studies
Active Not RecruitingNCT05399446

Eating-disorder prevention program for people with type 1 diabetes

About this title

Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes

Read the official source — NCT05399446
Behavioural studyAges 14–35Multiple countriesEating disorders
The study in practice

Understand this study

Who could participate?

Listed age limits: 14 years to 35 years.

Listed locations
Stanford and 3 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 1, 2023
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
280
Sponsor
Oslo University Hospital
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural
Locations
United States, Netherlands, Norway
Age range
From 14 Years to 35 Years
Official registry ID
NCT05399446
Official title
Show the full official title

Multi-site Trial of a Virtually Delivered Eating Disorder Prevention Program for Young People with Type 1 Diabetes

Recruitment & locations

Not recruiting

Stanford, United States · Boston, United States · Amsterdam, Netherlands

1 more locations
  • Oslo, Norway

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Oslo University Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: 14 years to 35 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies